Aardvark Therapeutics, Inc. Common Stock (AARD) vs Corbus Pharmaceuticals Holdings, Inc. (CRBP)
A side-by-side comparison of Aardvark Therapeutics, Inc. Common Stock and Corbus Pharmaceuticals Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AARD
Aardvark Therapeutics, Inc. Common Stock
$5.22HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CRBP
Corbus Pharmaceuticals Holdings, Inc.
$5.85HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — AARD vs CRBP
growth of $100 · dividends reinvested · last 2yAARD -63.5% (-39.6%/yr)CRBP -33.4% (-18.4%/yr)CRBP compounded faster over this window
AARD CRBP
AARD vs CRBP: by the numbers
- •AARD is the larger company ($114M vs $108M market cap).
Metrics side by side
Valuation
| Metric | AARD | CRBP |
|---|---|---|
| P/B ratio | 1.53 | 1.06 |
Profitability
| Metric | AARD | CRBP |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -93.44% | -99.67% |
| ROIC | -97.99% | -101.30% |
Growth (annualized)
| Metric | AARD | CRBP |
|---|---|---|
| Total return CAGR (5Y) | N/A | -28.32% |
Go deeper
Dig into the metrics
Aardvark Therapeutics, Inc. Common Stock ROECorbus Pharmaceuticals ROEAardvark Therapeutics, Inc. Common Stock operating marginCorbus Pharmaceuticals operating marginAardvark Therapeutics, Inc. Common Stock revenue growthCorbus Pharmaceuticals revenue growthAardvark Therapeutics, Inc. Common Stock free cash flowCorbus Pharmaceuticals free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.